95500-19-9

应用筛选条件

关键词:'95500-19-9'

显示 11-20 #N/A 951 条结果关于 "95500-19-9" 范围网站内容

Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine

Merck and The Jenner Institute today announced that The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.

Accelerated mAb Development Program – From Transfection to GMP Drug Substance in 9 Months

The accelerated mAb development program delivers GMP drug substance nine months from transfection. We designed the mAbExpress™ program to be fast, cost effective, and appropriate for the early clinical phase of your program, with regulatory support throughout.

How to Boost AAV Titer with Feed Supplementation in both HEK293 and Sf-9 Platforms

In this webinar, you will learn wow to boost AAV titers in HEK293 and Sf-9 cell lines as well as getting some insider tips on volume and timing optimization.

Analysis of 17 Cannabinoids in Hemp and Cannabis

HPLC separation of 17 important cannabinoids including CBD, delta 9 THC and THCA. Read the application note.

MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19

Merck Supports Eijkman Institute to Expedite Covid-19 Vaccine Development Research

Merck today announced the donation of research instruments and materials worth IDR 1.2 billion (€ 74,000) to support the efforts of Eijkman Institute for Molecular Biology, Indonesia.

Merck funds Indian Institute of Technology (IIT) Bombay for Covid-19 research

Merck today announced a donation of INR 1.7crore (194,000€) over two years to the Indian Institute of Technology (IIT), Bombay to support the development of clinical tests for Covid-19 disease severity assessment.

默克开学季，新人礼、首单礼，双重惊喜助力科研

默克开学季，新人礼、首单礼，双重惊喜助力科研 2023年9月1日到10月31日，开学季，新人礼，限时开启。

Coronavirus COVID-19 (SARS-CoV-2) Detection, Characterization, Vaccine and Therapy Production

We've consolidated our COVID-19 detection, characterization, and vaccine production product offers to help researchers responding to the coronavirus pandemic.

MILLIPLEX® Multiplex Assays for COVID-19 (SARS-CoV-2) Research Applications

MILLIPLEX® multiplex assays help to better understand the immune response to COVID-19 (SARS-CoV-2), including cytokine storm. Our MILLIPLEX® multiplex immunoassays offer researchers the ability to simultaneously quantitate a large number of analytes critical to understanding the immune response in humans.

2/96